PRELUDE CAPITAL MANAGEMENT, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$8,514,000
+1903.3%
125,029
+1522.7%
0.31%
+1357.1%
Q3 2020$425,000
+15.2%
7,705
+31.7%
0.02%
+5.0%
Q2 2020$369,000
+3254.5%
5,850
+4139.1%
0.02%
Q4 2019$11,0000.0%138
-38.1%
0.00%
Q3 2019$11,000
-98.8%
223
-98.8%
0.00%
-100.0%
Q2 2019$955,000
+72.7%
18,156
+73.8%
0.05%
+51.6%
Q1 2019$553,000
-77.1%
10,448
-83.5%
0.03%
-77.9%
Q3 2018$2,411,000
-7.5%
63,446
+10.0%
0.14%
-15.2%
Q2 2018$2,607,000
+44.4%
57,663
+54.3%
0.16%
+25.0%
Q1 2018$1,806,000
+881.5%
37,379
+696.0%
0.13%
+780.0%
Q4 2017$184,000
-38.3%
4,696
-51.0%
0.02%
-44.4%
Q3 2017$298,000
+51.3%
9,593
+33.2%
0.03%
+42.1%
Q2 2017$197,000
-27.8%
7,200
-2.7%
0.02%
-29.6%
Q1 2017$273,000
+320.0%
7,400
+64.4%
0.03%
+237.5%
Q4 2016$65,000
-66.1%
4,500
-45.8%
0.01%
-60.0%
Q3 2016$192,0008,3000.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 327,905$17,248,0009.44%
Asymmetry Capital Management, L.P. 314,217$16,528,0008.95%
Perceptive Advisors 5,775,726$303,803,0006.97%
NEXTHERA CAPITAL LP 142,305$7,485,0006.23%
Grace Capital 244,914$12,882,0006.14%
Broadfin Capital, LLC 316,619$16,654,0003.62%
Ghost Tree Capital, LLC 300,000$15,780,0003.27%
ArchPoint Investors 156,635$8,239,0002.61%
STANSBERRY ASSET MANAGEMENT, LLC 114,562$6,026,0002.37%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 13,928$733,0002.07%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders